CCL2 and serum lipopolysaccharide activity: MCP-1/CCL2 has a protective effect in murine endotoxemia [32], and administration of blocking monoclonal antibodies [33] or genetic deficiency of MCP-1/CCL2 is associated with increased mortality rates in mice with sepsis [34].